{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T22:53:40Z","timestamp":1648940020402},"reference-count":3,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T00:00:00Z","timestamp":1435795200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s40261-015-0305-7","type":"journal-article","created":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T07:42:34Z","timestamp":1435736554000},"page":"531-532","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fidaxomicin Pharmacokinetics in Humans: Is There a Role of Biliary Excretion?"],"prefix":"10.1007","volume":"35","author":[{"given":"Nuggehally R.","family":"Srinivas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,2]]},"reference":[{"key":"305_CR1","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4140\/TCP.n.2014.614.","volume":"29","author":"EB Chahine","year":"2014","unstructured":"Chahine EB, Sucher AJ, Mantei K. Fidaxomicin: a novel macrolide antibiotic for Clostridium difficile infection. Consult Pharm. 2014;29:614\u201324.","journal-title":"Consult Pharm."},{"key":"305_CR2","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1099\/jmm.0.029470-0","volume":"60","author":"F Babakhani","year":"2011","unstructured":"Babakhani F, Gomez A, Robert N, Sears P. Killing kinetics of fidaxomicin and its major metabolite, OP-1118, against Clostridium difficile. J Med Microbiol. 2011;60:1213\u20137.","journal-title":"J Med Microbiol."},{"key":"305_CR3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s40261-015-0291-9","volume":"35","author":"H Oshima","year":"2015","unstructured":"Oshima H, Yamazaki T, Benner L, Miki T, Michon I, Wojtkowski T, et al. Comparison of the safety, tolerability, and pharmacokinetics of fidaxomicin in healthy Japanese and caucasian subjects. Clin Drug Invest. 2015;35:375\u201384.","journal-title":"Clin Drug Invest."}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-015-0305-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-015-0305-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-015-0305-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T19:28:55Z","timestamp":1559503735000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-015-0305-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,2]]},"references-count":3,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["305"],"URL":"https:\/\/doi.org\/10.1007\/s40261-015-0305-7","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,2]]}}}